<p>The US Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's Covid-19 antibody therapy, an experimental treatment given to US President Donald Trump that he said helped cure him of the disease.</p>.<p>The FDA said that the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate Covid-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe <a href="https://bit.ly/3kTd6fR">Covid-19</a>.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-news-live-updates-india-world-Covid-19-vaccine-bengaluru-karnataka-mumbai-maharashtra-chennai-tamil-nadu-delhi-kerala-uttar-pradesh-west-bengal-kolkata-cases-deaths-recoveries-health-ministry-Oxford-918496.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>This includes those who are 65 years of age or older or who have certain chronic medical conditions.</p>.<p>The agency said that the antibodies are not authorized for patients who are hospitalized due to Covid-19 or require oxygen therapy due to Covid-19. A benefit of casirivimab and imdevimab treatment has not been shown in patients hospitalised due to Covid-19.</p>
<p>The US Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's Covid-19 antibody therapy, an experimental treatment given to US President Donald Trump that he said helped cure him of the disease.</p>.<p>The FDA said that the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate Covid-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe <a href="https://bit.ly/3kTd6fR">Covid-19</a>.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-news-live-updates-india-world-Covid-19-vaccine-bengaluru-karnataka-mumbai-maharashtra-chennai-tamil-nadu-delhi-kerala-uttar-pradesh-west-bengal-kolkata-cases-deaths-recoveries-health-ministry-Oxford-918496.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>This includes those who are 65 years of age or older or who have certain chronic medical conditions.</p>.<p>The agency said that the antibodies are not authorized for patients who are hospitalized due to Covid-19 or require oxygen therapy due to Covid-19. A benefit of casirivimab and imdevimab treatment has not been shown in patients hospitalised due to Covid-19.</p>